COVID-19 protection for elderly and immunocompromised individuals

Despite decreasing risks associated with COVID-19 due to vaccines and prior exposure, elderly and immunocompromised individuals remain at elevated risk. Updated vaccines and a new monoclonal antibody, Pemgarda, can provide increased protection for these groups. The CDC has updated guidelines for isolation and recommends multiple doses of the updated vaccines for higher-risk individuals.